Literature DB >> 16378679

Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.

Uros Rot1, Anton Mesec.   

Abstract

Effective therapy in the earliest stages of multiple sclerosis (MS) demands early correct diagnosis. Retrospective analysis included 130 patients (90 women) with a median age of 35.5 years, median duration of the disease of 2 years and median EDSS score of 3.0. Twenty-seven patients had clinically isolated syndrome (CIS) suggestive of MS, 66 relapsing-remitting (RR) MS, 19 secondary progressive (SP) MS and 18 primary progressive (PP) MS. The predominant symptoms were sensory in 52% of the patients with CIS compared to 27% in patients with RRMS, whereas they were more often motor in patients with PPMS. Patients with CIS had higher CSF cell counts than patients diagnosed in later stages of the disease and oligoclonal bands were found in 89% of all patients without statistically significant differences between the subgroups. Prolonged latencies of visual evoked potentials (VEP) were found in only 29% of patients with CIS compared to 66% in RRMS, 75% in SPMS and 65% of PPMS patients. Fifty-six percent of patients with CIS, 88% with RRMS, 74% with SPMS and 78% of patients with PPMS fulfilled modified the Barkhof et al. MRI criteria at the time of diagnosis. Patients in early MS often present with sensory symptoms. Brain MRI can be inconclusive in over 40% of patients with CIS but the elevated CSF cell count and positive oligoclonal bands are helpful in establishing the diagnosis of CIS suggestive of MS. In later stages of the disease the combination of clinical features, MRI, prolonged VEP latencies and positive CSF oligoclonal bands secures the correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378679     DOI: 10.1016/j.clineuro.2005.11.021

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

Review 1.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

2.  Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.

Authors:  Niphon Chirapapaisan; Sawarin Laotaweerungsawat; Wanicha Chuenkongkaew; Patthanee Samsen; Ngamkae Ruangvaravate; Atiporn Thuangtong; Nacha Chanvarapha
Journal:  Doc Ophthalmol       Date:  2014-10-21       Impact factor: 2.379

3.  Characterization of functioning in multiple sclerosis using the ICF.

Authors:  Lisa Holper; Michaela Coenen; Andrea Weise; Gerold Stucki; Alarcos Cieza; Jürg Kesselring
Journal:  J Neurol       Date:  2010-01       Impact factor: 4.849

4.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04

5.  Optic neuritis presenting with amaurosis fugax.

Authors:  Amer M Awad; Bachir Estephan; Worthy Warnack; Olaf Stüve
Journal:  J Neurol       Date:  2009-09-02       Impact factor: 4.849

6.  Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography.

Authors:  Timm Oberwahrenbrock; Sven Schippling; Marius Ringelstein; Falko Kaufhold; Hanna Zimmermann; Nazmiye Keser; Kim Lea Young; Jens Harmel; Hans-Peter Hartung; Roland Martin; Friedemann Paul; Orhan Aktas; Alexander U Brandt
Journal:  Mult Scler Int       Date:  2012-07-25

7.  Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment.

Authors:  Sigliti-Henrietta Pelidou; Sotirios Giannopoulos; Sotiria Tzavidi; Georgios Lagos; Athanassios P Kyritsis
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.